# SAM #HT9426-27-NOI-049825

Sole-source purchase of two MP201 prodrug batches and research support

**Buyer:** Defense Health Agency
**Posted:** November 16, 2026
**Respond By:** December 31, 2026
**Identifier:** HT9426-27-NOI-049825
**NAICS:** 541715, 325412

The Defense Health Agency plans to sole-source MP201 prodrug and related research support for Walter Reed Army Institute of Research studies.
- **Buyer:** Defense Health Agency Contracting Activity, for WRAIR’s Center for Military Psychiatry and Neuroscience, Integrative Systems Biology Branch.
- **Sole-source supplier and product source:** Mitochon Pharmaceuticals, Inc.; the notice describes MP201 as proprietary.
- **Products:** Two freshly synthesized batches of MP201 (part number MP201), for oral administration and mouse dosage testing at approximately 8–80 mg/kg body weight.
- **Related support:** Quality-control documentation, dosage background information, and assistance preparing research reports and manuscripts.
- **Timing and value:** The provided notice does not specify a performance period or estimated contract value.

### Description

<p>See Attachment.&nbsp;Notice of Intent to Sole Source - M201 ProDrug_Approved for posting 16NOV26</p>

[View original listing](https://sam.gov/opp/f9ba736f43b5425bbbcd8d523236bba8/view)
